PARINDA FRUCHTMAN: Open Payments
NPI 1831277425 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,235 in 93 payments from 23 companies in 2025. Trend: 2023 $2,696 · 2024 $1,929 · 2025 $2,235
Food & beverage: $2,235
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $591 |
| AstraZeneca Pharmaceuticals LP | 7 | $433 |
| Novo Nordisk Inc | 14 | $318 |
| Paratek Pharmaceuticals, Inc. | 4 | $155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $97 |
| GlaxoSmithKline, LLC. | 5 | $80 |
| Collegium Pharmaceutical, Inc. | 4 | $76 |
| Verona Pharma, Inc. | 4 | $70 |
| Forte Bio-Pharma LLC | 2 | $60 |
| PFIZER INC. | 3 | $58 |
Products named: UBRELVY, Wegovy, AIRSUPRA, FARXIGA, NUZYRA, QULIPTA, RELISTOR, VRAYLAR.
Industry payments across NC — which companies pay providers there.
